Statins reduce testicular and ocular VEGF: A potential compromise to microcirculation
Keywords: آتورواستاتین; Microcirculation; Testis; Eye; VEGF; Atorvastatin; Diabetes mellitus;
مقالات ISI آتورواستاتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Design and characterization of a perivascular PLGA coated PET mesh sustaining the release of atorvastatin for the prevention of intimal hyperplasia
Keywords: آتورواستاتین; Mesh; PLGA â Poly(d,l-lactide-co-glycolide); PLCL â Poly(d,l-lactide-co-caprolactone); Atorvastatin; Coating; Perivascular; Polyethylene terephthalate;
Removal of atorvastatin in water mediated by CuFe2O4 activated peroxymonosulfate
Keywords: آتورواستاتین; Atorvastatin; Peroxymonosulfate; CuFe2O4; Pathways; Intermediate distribution;
Imaging the porous structure in the core of degrading PLGA microparticles: The effect of molecular weight
Keywords: آتورواستاتین; PLGA microparticles; Pores; Molecular weight; Erosion; Swelling; Drug release mechanism; Atorvastatin;
Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials
Keywords: آتورواستاتین; Apolipoprotein CIII; Statins; Cardiovascular disease; Atorvastatin; Rosuvastatin; Lovastatin;
Atorvastatin induces MicroRNA-145 expression in HEPG2 cells via regulation of the PI3K/AKT signalling pathway
Keywords: آتورواستاتین; Atorvastatin; HepG2; miRNA-145; PI3K/Akt;
In vivo evaluation of chitosan based local delivery systems for atorvastatin in treatment of periodontitis
Keywords: آتورواستاتین; Inflammation; Periodontitis; Chitosan; Local delivery; Atorvastatin; In vivo;
Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort
Keywords: آتورواستاتین; Liquid chromatography-mass spectrometry; Assay validation; Atorvastatin; Bisoprolol; Clopidogrel;
Atorvastatin, losartan and captopril may upregulate IL-22 in hypertension and coronary artery disease; the role of gene polymorphism
Keywords: آتورواستاتین; Atorvastatin; Captopril; Coronary artery disease; Hypertension; Interleukin-22; Losartan; Polymorphism;
Standardized fraction of Xylocarpus moluccensis fruits improve vascular relaxation and plaque stability in dyslipidemic models of atherosclerosis
Keywords: آتورواستاتین; ABC; ATP-binding cassette; Atorva; atorvastatin; CE; cholesteryl ester; eNOS; endothelial nitric oxide synthase; FC; free cholesterol; HDL; high density lipoprotein; HMGCR; 3-hydroxy-3-methylglutaryl coenzyme A reductase; iNOS; inducible nitric oxide synt
In vitro binding interaction of atorvastatin with calf thymus DNA: multispectroscopic, gel electrophoresis and molecular docking studies
Keywords: آتورواستاتین; Atorvastatin; DNA interaction; Fluorescence study; Groove binding; Molecular docking; DNA cleavage;
Sodium tanshinone IIA sulfonate promotes endothelial integrity via regulating VE-cadherin dynamics and RhoA/ROCK-mediated cellular contractility and prevents atorvastatin-induced intracerebral hemorrhage in zebrafish
Keywords: آتورواستاتین; Sodium tanshinone IIA sulfonate; Salvia miltiorrhiza; Hemorrhagic stroke; Atorvastatin; ROCK;
Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes
Keywords: آتورواستاتین; Cholesterol efflux; HDL subpopulations; Type 2 diabetes; Atorvastatin; HDL chemical composition;
Inhibition of Organic Anion Transporting Polypeptide 1B1 and 1B3 by Betulinic Acid: Effects of Preincubation and Albumin in the Media
Keywords: آتورواستاتین; transporters; natural products; drug interactions; drug transport; food interactions; ATV; atorvastatin; BA; betulinic acid; BSA; bovine serum albumin; CysA; cyclosporin A; DCF; 2â²,7â²-dichlorofluorescein; DDIs; drug-drug interactions; DPBS; Dulbecco's
Atorvastatin impaired glucose metabolism in C2C12 cells partly via inhibiting cholesterol-dependent glucose transporter 4 translocation
Keywords: آتورواستاتین; ABC; ATP-binding cassette; Akt; Protein kinase B; AUC; area under the concentrationtime curve; BW; body weight; CMC; carboxyl methyl cellulose; ERK; extracellular-regulated protein kinase; GCK; glucokinase; GLUT2; glucose transporter 2; GLUT4; glucose tra
Correlation of compliance to statin therapy with lipid profile and serum HMGCoA reductase levels in dyslipidemic patients
Keywords: آتورواستاتین; Dyslipidemia; Compliance; HMGCoA reductase; Atorvastatin; Rosuvastatin;
Atorvastatin protected from paraquat-induced cytotoxicity in alveolar macrophages via down-regulation of TLR-4
Keywords: آتورواستاتین; Alveolar macrophages; Atorvastatin; Cytotoxicity; Paraquat; Toll like receptor-4;
Rosuvastatin safety: An experimental study of myotoxic effects and mitochondrial alterations in rats
Keywords: آتورواستاتین; OATP; Organic anion transporting polypeptide; CK; Creatine Kinase; LDH; lactate dehydrogenase enzyme; Rosuvastatin; Myopathy; Mitochondria; Atorvastatin;
Atorvastatin as a promising anticryptococcal agent
Keywords: آتورواستاتین; Cryptococcus gattii; Drug repositioning; Atorvastatin;
Atorvastatin prevents Angiotensin II induced myocardial hypertrophy in vitro via CCAAT/enhancer-binding protein β
Keywords: آتورواستاتین; Atorvastatin; Myocardial hypertrophy; Apoptosis; C/EBPβ; PGC-1α; (MMP); Mitochondrial membrane potential; (Ang II); Angiotensin II; (C/EBPβ); CCAAT/enhancer-binding protein β; (CCCP); Carbonyl cyanide 3-chlorophenylhydrazone; (DMEM); Dulbecco's modifi
Cassia auriculata flower extract attenuates hyperlipidemia in male Wistar rats by regulating the hepatic cholesterol metabolism
Keywords: آتورواستاتین; Et- CAF; ethanolic extract of Cassia auriculata flower; HMGR; HMG-CoA reductase; HMGS; HMGCoA synthase; SREBP-1c; sterol regulatory element binding protein -1c; SREBP-2; sterol regulatory element binding protein- 2; CYP7A1; cholesterol 7 α-hydroxylase; A
Effect of dietary n-3 fatty acids supplementation on fatty acid metabolism in atorvastatin-administered SHR.Cg-Leprcp/NDmcr rats, a metabolic syndrome model
Keywords: آتورواستاتین; Metabolic syndrome; N-3 PUFA; Atorvastatin; Hypercholesterolemia and hyperlipidemia;
Effects of atorvastatin and diet interventions on atherosclerotic plaque inflammation and [18F]FDG uptake in Ldlrâ/âApob100/100 mice
Keywords: آتورواستاتین; Atherosclerosis; Ldlrâ/âApob100/100 mouse; Atorvastatin; Inflammation; [18F]FDG PET/CT; [18F]FDG; 2-deoxy-2-[18F]-fluoro-d-glucose; ARG; autoradiography; HFDÂ +Â A; high-fat diet with added atorvastatin; Ldlrâ/âApob100/100; mouse model deficient i
Influence of ezetimibe in addition to high-dose atorvastatin therapy on plaque composition in patients with ST-segment elevation myocardial infarction assessed by serial
Keywords: آتورواستاتین; Atorvastatin; Ezetimibe; IVUS; iMap;
Atorvastatin from target screening attenuates endothelial cell tube formation and migration by regulating urokinase receptor-related signaling pathway and F/G actin
Keywords: آتورواستاتین; angiogenesis; atorvastatin; cytoskeleton; urokinase receptor;
Atorvastatin alleviates cardiomyocyte apoptosis by suppressing TRB3 induced by acute myocardial infarction and hypoxia
Keywords: آتورواستاتین; AMI; atorvastatin; cardiomyocytes; hypoxia; TRB3;
1H NMR-based metabolomics reveals sub-lethal toxicity of a mixture of diabetic and lipid-regulating pharmaceuticals on amphibian larvae
Keywords: آتورواستاتین; Pharmaceutical; Amphibian development; Metabolomics; Nuclear magnetic resonance; Metformin; Atorvastatin; Bezafibrate;
Development of validated HPLC-UV method for simultaneous determination of Metformin, Amlodipine, Glibenclamide and Atorvastatin in human plasma and application to protein binding studies
Keywords: آتورواستاتین; Metformin; Glibenclamide; Amlodipine; Atorvastatin; HPLC-UV; Protein binding; Glycated human serum albumin;
Coenzyme Q10 protects against statin-induced myotoxicity in zebrafish larvae (Danio rerio)
Keywords: آتورواستاتین; ATV; Atorvastatin; EM; embryo medium; HMGCR; 3-hydroxy-3-methylglutaryl-CoA reductase; hpf; hours post-fertilization; PTS; polyoxyethanyl-α-tocopheryl sebacate; Zebrafish; Larvae; CoQ10; Myotoxicity; Muscle atrophy; Mitochondria;
Cu@SnS/SnO2 nanoparticles as novel sorbent for dispersive micro solid phase extraction of atorvastatin in human plasma and urine samples by high-performance liquid chromatography with UV detection: Application of central composite design (CCD)
Keywords: آتورواستاتین; Atorvastatin; Central composite design; Ultrasound assisted extraction; HPLC-UV; Human plasma samples; Plackett-Burman design;
Enzymatic preparation of optically pure t-butyl 6-chloro-(3R,5S)-dihydroxyhexanoate by a novel alcohol dehydrogenase discovered from Klebsiella oxytoca
Keywords: آتورواستاتین; Alcohol dehydrogenase; T-butyl 6-chloro-(3R,5S)-dihydroxyhexanoate; Klebsiella oxytoca; Whole-cell biocatalyst; Rosuvastatin; Atorvastatin;
Atorvastatin reduces lipid accumulation in the liver by activating protein kinase A-mediated phosphorylation of perilipin 5
Keywords: آتورواستاتین; Perilipin-5; Atorvastatin; Triglyceride; Non-alcoholic fatty liver disease; Lipolysis; Protein kinase A; Phosphorylation;
Protective effect of atorvastatin on d-galactose-induced aging model in mice
Keywords: آتورواستاتین; Atorvastatin; Aging; d-Galactose;
CuO nanoparticles-catalyzed hydrogen peroxide-sodium hydrogen carbonate chemiluminescence system used for quenchometric determination of atorvastatin, rivastigmine and topiramate
Keywords: آتورواستاتین; Chemiluminescence; CuO nanoparticles; Atorvastatin; Rivastigmine; Topiramate; Sodium hydrogen carbonate;
Effects of atorvastatin treatment on left ventricular diastolic function in peritoneal dialysis patients-The ALEVENT clinical trial
Keywords: آتورواستاتین; Left ventricular diastolic dysfunction; Atorvastatin; Inflammation; Tissue Doppler imaging; Peritoneal dialysis;
Statin therapy exacerbates alcohol-induced constriction of cerebral arteries via modulation of ethanol-induced BK channel inhibition in vascular smooth muscle
Keywords: آتورواستاتین; AICAC; alcohol-induced cerebral artery constriction; ANOVA; analysis of variance; BK; voltage-/calcium-gated potassium channel of large conductance; CLR; cholesterol; EtOH; ethanol (ethyl alcohol); HMG-CoA; 3-hydroxy-3-methylglutaryl-coenzyme A; I/O; insi
Atorvastatin inhibits miR-143 expression: A protective mechanism against oxidative stress in cardiomyocytes
Keywords: آتورواستاتین; Atorvastatin; miR-143; Oxidative stress; Apoptosis;
Loading of atorvastatin and linezolid in β-cyclodextrin-conjugated cadmium selenide/silica nanoparticles: A spectroscopic study
Keywords: آتورواستاتین; CdSe nanoparticles; β-cyclodextrin; Atorvastatin; Linezolid; Drug loading; FRET;
Pleurésie induite par l'atorvastatine
Keywords: آتورواستاتین; Pleurésie médicamenteuse; Statine; Atorvastatine; Drug-induced pleural effusion; Statins; Atorvastatin;
Gene expression profiling reveals Nef induced deregulation of lipid metabolism in HIV-1 infected T cells
Keywords: آتورواستاتین; HIV-1; Nef; Microarray; Gene expression; Lipid metabolism; Atorvastatin; Ranolazine;
Original articleDevelopment and validation of RP-HPLC method for determination of Atorvastatin calcium and Nicotinic acid in combined tablet dosage form
Keywords: آتورواستاتین; Atorvastatin; Nicotinic acid; Validation; RP-HPLC; Simultaneous estimation; Tablet dosage form;
Atorvastatin suppresses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB signaling in PMA-stimulated THP-1 monocytes
Keywords: آتورواستاتین; Atorvastatin; NLRP3 inflammasome; TLR4/MyD88/NF-κB; Atherosclerosis; Monocytes
Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the PROFACE trial (PROphylaxis of postoperative atrial Fibrillation After Cardiac surgEry)
Keywords: آتورواستاتین; Atrial fibrillation; Atorvastatin; Inflammation; Surgery; Trials
Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2Â diabetes mellitus on hemodialysis
Keywords: آتورواستاتین; atorvastatin; cardiovascular and cerebrovascular events; diabetes; hemodialysis; long-term; mortality; statin;
Inverse relationship between high-density lipoprotein cholesterol raising and high-sensitivity C-reactive protein reduction in older patients treated with lipid-lowering therapy
Keywords: آتورواستاتین; Atorvastatin; Ezetimibe; HDL-C; hsCRP; Hypercholesterolemia; Vytorin;
NanopartÃculas calcificantes como factor etiológico del desarrollo de hiperplasia y calcificación vascular
Keywords: آتورواستاتین; Calcificación arterial; Atorvastatina; NanopartÃculas calcificantes; Hiperplasia; Arterial calcification; Atorvastatin; Calcifying nanoparticles; Hyperplasia;
Atorvastatin for the Prophylaxis of Acute Graft-versus-Host Disease in Patients Undergoing HLA-Matched Related Donor Allogeneic Hematopoietic Stem Cell Transplantation (allo-HCT)
Keywords: آتورواستاتین; Atorvastatin; Allogeneic hematopoietic stem cell transplant; Graft-versus-host-disease
Atorvastatin enhances angiogenesis to reduce subdural hematoma in a rat model
Keywords: آتورواستاتین; Subdural hematoma; Atorvastatin; Angiogenesis; Rat model
Atorvastatin attenuates contrast-induced nephropathy by modulating inflammatory responses through the regulation of JNK/p38/Hsp27 expression
Keywords: آتورواستاتین; Contrast-induced nephropathy (CIN); Atorvastatin; Inflammatory processes; Apoptosis; JNK/p38 MAPK pathway
Amlodipine and atorvastatin improve ventricular hypertrophy and diastolic function via inhibiting TNF-α, IL-1β and NF-κB inflammatory cytokine networks in elderly spontaneously hypertensive rats
Keywords: آتورواستاتین; TNF-α, tumor necrosis factor-alpha; IL-1β, Interleukin-1β; Hs-CRP, high sensitive C reactive protein; NF-κb, nuclear factor-kappa B; IκB, inhibitor-kappa B; MMP, matrix metalloproteinase; DEPC, diethypyocarbonateAmlodipine; Atorvastatin; Inflammatory cyto